• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ATDC

ATDC

Menu
  • About
    • Impact
    • Team
    • Sponsors & Partners
    • Mentors
    • Contact Us
    • Locations
      • ATDC HQ (Midtown Atlanta)
      • ATDC @ ALPHARETTA
      • ATDC @ ATHENS
      • ATDC @ AUGUSTA
      • ATDC @ FORSYTH COUNTY
      • ATDC @ PEACHTREE CORNERS
      • ATDC @ SAVANNAH
  • How We Help
    • Overview
    • Classes
    • Capital
    • Customers
    • Georgia Tech Resources
  • Portfolio
    • Overview
    • Criteria
    • ATDC Accelerate
    • ATDC Signature
    • Graduates
    • Testimonials
  • Industry Vertical Markets
    • 5G
  • Events
  • News + Jobs
    • News
    • ATDC Company Job Board
  • Login
  • Join

Q3 Top Venture Deals – from peHub

October 21, 2009 by ei2admin

Good to be cleantech or microblog!

1. Solyndra (photovoltaics for solar energy panels), five rounds, $285.9 million

2a. Twitter (microblog), 7 rounds, $100 million

2b. WastePro USA (waste disposal and recycling), later stage, $100 million

2c. Facebook (social network), corporate stage, $100 million

3. Tesla Motors (electric cars), 6 or 7 rounds, $82.5 million

4. Pacific Biosciences (gene sequencing), 6 rounds, $67.9 million

5. Canopy Financial (technology to lower costs for corporate healthcare benefits), 3 rounds, $62.5 million

6. Serious Materials (ecofriendly building materials), 3 rounds, $60 million

7. Meru Networks (wireless infrastructure for businesses), 9 rounds, $57.5 million

8. Kosmos Energy (oil and gas exploration in Africa), 14 rounds, $56.5 million

9a. Calypso Medical, (radiation therapy), 6 rounds, $55 million

9b. RuffaloCODY, (fundraising and enrollment management services), 4 rounds $55 million

10. Complete Genomics (gene sequencing and drug development), 4 rounds, $45 million

11. Oraya Therapeutics (robotically controlled treatments for inflammatory eye disease), 3 rounds, $42 million

12a. Direct Flow Medical (aortic tissue valve prosthesis for people with heart disease), 3 rounds, $40 million

12b. Adamas Pharmaceuticals (small molecule drugs for infectious diseases, including influenza A), 3 rounds, $40 million

13. Epizyme, (drugs to treat diseases based on gene functions and mutations, i.e. epigenetics), 2 rounds, $32 million

Category iconATDC News

What is ATDC?

Footer

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

© Copyright 1986 - 2023. Advanced Technology Development Center.
All Rights Reserved.
Tech Square  |  75 5th Street NW, Suite 2000  |  Atlanta, GA 30308
t: (404) 894-3575  |  f: (404) 894-4545 Terms of Use | Contact Us